Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Explore how a total market ETF and a mutual fund differ in diversification, costs, and risk. This quick primer helps investors decide which fits their retirement strategy.
28,608 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...
As AI demand reshapes chips, Intel and Arm sit at opposite ends of the risk spectrum. This analysis weighs which AI-e...
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
Analysts lean bullish on Apollo Global Management after a flurry of dealmaking, with elevated price targets and visib...
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
Super Micro Computer posted a margin-led earnings surprise that beat expectations and lifted full-year guidance, prom...
Unilever faces a pivotal turnaround path as portfolio reshaping and a buyback program align with a potential rally to...
Investors are weighing whether lululemon stocks stage turnaround is still on the table. This guide breaks down the fa...
Tariff headlines grab attention, but everyday shopping never stops. This guide highlights two tariff-proof retail sto...
A prominent billionaire asserts the market is underestimating how far the Federal Reserve may go with rate cuts. This...
On June 20, 2026, a Ramsey Show–style caller received a blunt reality check about retirement planning after outlining...